BEDFORD, Mass., March 7, 2007 /PRNewswire-FirstCall/ -- Hologic, Inc, (NASDAQ: HOLX), a leading provider of women's diagnostic imaging systems and state-of-the-art digital imaging systems, announced today the company has been selected as the recipient of the 2007 Frost & Sullivan awards for Market Leadership and Product Line Strategy.
In selecting Hologic for the Market Leadership award, Frost & Sullivan noted the Company has gained a leadership position in women's imaging in just a few short years. Frost & Sullivan analysts estimate Hologic gained 56 percent of the North American digital mammography market revenues in 2006.
In giving the Product Line Strategy award to Hologic, Frost & Sullivan recognized Hologic for being "intrically involved with the newest advances in women's healthcare and placing great emphasis on improving breast imaging for screening and diagnostic purposes."
"It is gratifying and exciting Frost & Sullivan analysts are acknowledging Hologic as a market leader in developing innovative imaging solutions targeted at improving women's health," said Jack Cumming, Hologic's Chairman and CEO. "These awards exemplify and recognize the commitment we have made to our customers and the emphasis we place on improving breast imaging for screening and diagnostic purposes. We will do our best to honor these awards in the years to come."
Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostic and medical imaging systems dedicated to serving the healthcare needs of women, and a leading developer of innovative imaging technology for digital radiography and breast imaging. Hologic's core business units are focused on mammography and breast biopsy, osteoporosis assessment, and mini C- arm and extremity MRI imaging for orthopedic applications. For more information visit www.hologic.com.
About Frost and Sullivan
Frost & Sullivan is an international marketing consulting firm. The Frost & Sullivan Technology Leadership of the Year Award recognizes technology developments that are expected to bring significant contributions to the industry in terms of adoption, change, and competitive posture. Founded in 1961, Frost & Sullivan is recognized as a global marketing research and solution leader, with offices located worldwide: Silicon Valley, New York, Texas, London, Paris, Frankfurt, Beijing, Tokyo, Singapore, and Mumbai. For further information contact http://www.frost.com/.
Forward Looking Disclaimer
This News Release contains forward-looking information that involves risks and uncertainties, including statements about Hologic's plans, objectives, expectations and intentions. Such statements include, without limitation, statements by Frost & Sullivan and Hologic regarding Hologic's market share and the anticipated benefits of Hologic's breast imaging systems. These forward-looking statements are subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those anticipated. Factors that could cause actual results to materially differ include, without limitation: uncertainties inherent in the development of new products and the enhancement of existing products, including technical and regulatory risks, cost overruns and delays; the risk that newly introduced products may contain undetected errors or defects or otherwise not perform as anticipated; the early stage of market development for digital mammography products; technical innovations that could render products marketed or under development by Hologic obsolete; competition; and reimbursement policies for the use of Hologic's products and products under development. Other factors that could adversely affect Hologic's business and prospects are described in Hologic's filings with the Securities and Exchange Commission. Hologic expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any such statements to reflect any change in Hologic's expectations or any change in events, conditions or circumstances on which any such statement is based.
Executive Vice President and CFO
Director, Investor Relations
Tel: (781) 999-7377
SOURCE: Hologic, Inc.